Bendamustine/Rituximab Followed by High-dose Cytarabine/Rituximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bendamustine and rituximab followed by high-dose cytarabine and rituximab that can be used for the treatment of mantle cell lymphoma (MCL).

**Synonyms:** - Bendamustine-Rituximab Followed by High-dose Cytarabine-Rituximab - Bendamustine/Rituxan Followed by HiDAC/Rituxan - Bendamustine/Rituximab Followed by High-dose Cytarabine/Rituximab